Ageas: Reinsurance partnership with TRIGLAV, taking QS on Italian motor direct insurance Belgian Telecoms: Digi introduces a new mobile subscription at €3. Kinepolis: Box office in US/Canada up 76% YoY while France visitors were down 25%. NN Group & ASR: Dutch coalition collapse not affecting Dutch Pension Reform. SBM Offshore: Farewell Aseng after 13.5 years of service. Events Calendar
Aedifica and Cofinimmo: Agreement reached to create Europe's leading Healthcare REIT. bpost: CMD press release; #Reshape 2029. D'Ieteren: Belgian new car registrations down 11.7% in May, VW down 13.5% Fugro: Meeting with CEO & IR; 2Q25 also has its challenges. UCB: Peer Moonlake held takeover talks with US Merck, FT reports
Ageas reports on the progress of share buy-back programme Further to the initiation of the share buy-back programme announced on 28 August 2024, Ageas reports the purchase of 68,932 Ageas shares in the period from 26-05-2025 until 30-05-2025. DateNumber ofSharesTotal amount(EUR)Average price(EUR)Lowest price(EUR)Highest price(EUR)26-05-202510,760618,65257.5057.3557.6027-05-20259,349537,49657.4957.2557.7528-05-202514,400823,52257.1957.0557.4529-05-202519,3651,109,59557.3056.9557.9530-05-202515,058865,11957.4557.2057.80Total68,9323,954,38557.3756.9557.95 Since the start of the share buy-back ...
Rapport d’Ageas sur le programme de rachat d’actions Dans le cadre du programme de rachat d’actions annoncé le 28 août 2024, Ageas indique que 68.932 actions Ageas ont été achetées durant la période du 26-05-2025 au 30-05-2025. DateNombred’actionsMontant total(EUR)Cours moyen(EUR)Cours le plus bas (EUR)Cours le plus élevé (EUR)26-05-202510.760618.65257,5057,3557,6027-05-20259.349537.49657,4957,2557,7528-05-202514.400823.52257,1957,0557,4529-05-202519.3651.109.59557,3056,9557,9530-05-202515.058865.11957,4557,2057,80Total68.9323.954.38557,3756,9557,95 Depuis le lancement du programme de racha...
Ageas rapporteert over de inkoop van eigen aandelen Naar aanleiding van het aandelen-inkoopprogramma dat op 28 augustus 2024 aangekondigd werd, maakt Ageas bekend dat er 68.932 eigen aandelen ingekocht werden tussen 26-05-2025 en 30-05-2025. DatumAantalaandelenTotaal Bedrag(EUR)Gemiddelde koers(EUR)Laagste koers(EUR)Hoogste koers(EUR)26-05-202510.760618.65257,5057,3557,6027-05-20259.349537.49657,4957,2557,7528-05-202514.400823.52257,1957,0557,4529-05-202519.3651.109.59557,3056,9557,9530-05-202515.058865.11957,4557,2057,80Totaal68.9323.954.38557,3756,9557,95 Vanaf de start van het aandelen-i...
Ageas reports on the progress of share buy-back programme Ageas reports on the progress of share buy-back programme Further to the initiation of the share buy-back programme announced on 28 August 2024, Ageas reports the purchase of 72,819 Ageas shares in the period from 19-05-2025 until 23-05-2025. DateNumber ofSharesTotal amount(EUR)Average price(EUR)Lowest price(EUR)Highest price(EUR)19-05-202514,395819,10056.9056.7557.0520-05-20255,545317,46357.2557.0057.6021-05-20258,270474,39957.3657.1557.6022-05-20259,348537,49857.5057.3057.7523-05-202535,2612,007,46956.9356.1057.65Total72,8194,15...
Rapport d’Ageas sur le programme de rachat d’actions Rapport d’Ageas sur le programme de rachat d’actions Dans le cadre du programme de rachat d’actions annoncé le 28 août 2024, Ageas indique que 72.819 actions Ageas ont été achetées durant la période du 19-05-2025 au 23-05-2025. DateNombred’actionsMontant total(EUR)Cours moyen(EUR)Cours le plus bas (EUR)Cours le plus élevé (EUR)19-05-202514.395819.10056,9056,7557,0520-05-20255.545317.46357,2557,0057,6021-05-20258.270474.39957,3657,1557,6022-05-20259.348537.49857,5057,3057,7523-05-202535.2612.007.46956,9356,1057,65Total72.8194.155.92957,07...
Ageas rapporteert over de inkoop van eigen aandelen Ageas rapporteert over de inkoop van eigen aandelen Naar aanleiding van het aandelen-inkoopprogramma dat op 28 augustus 2024 aangekondigd werd, maakt Ageas bekend dat er 72.819 eigen aandelen ingekocht werden tussen 19-05-2025 en 23-05-2025. DatumAantalaandelenTotaal Bedrag(EUR)Gemiddelde koers(EUR)Laagste koers(EUR)Hoogste koers(EUR)19-05-202514.395819.10056,9056,7557,0520-05-20255.545317.46357,2557,0057,6021-05-20258.270474.39957,3657,1557,6022-05-20259.348537.49857,5057,3057,7523-05-202535.2612.007.46956,9356,1057,65Totaal72.8194.155.9...
This conference book is your guide to our annual Benelux Local Champions Conference set to take place on Tuesday, 27 May 2025 at our historic building at Grand Place in Brussels. This event offers the possibility to have one-on-one meetings and/or small group meetings with the following Benelux companies and their top management & IR. ACKERMANS & VAN HAAREN | AGEAS | AHOLD DELHAIZE | AKZONOBEL | ARCADIS | AZELIS | CORBION | GBL | KBC GROUP | LOTUS BAKERIES | MELEXIS | PROXIMUS | SOFINA | UMIC...
Onward has successfully completed the 4th and 5th implants of its ARC-BCI brain-computer interface in two additional spinal cord injury patients. The ARC-BCI system combines Onward's ARC-IM neurostimulation platform with Clinatec's WIMAGINE BCI device to enable AI-driven, thought-controlled movement. With promising prior data on safety and signal stability, WIMAGINE is seen as a strong contender in the competitive BCI space. We reiterate our €10.4 TP and Buy rating.
ONWARD Medical Advances Brain-Computer Interface Leadership with Fourth and Fifth Successful BCI Implants Groundbreaking procedures extend ONWARD’s leadership in the rapidly emerging brain-computer interface (BCI) fieldARC-BCI Therapy is designed to restore thought-driven movement after spinal cord injury and other movement disabilitiesONWARD’s BCI breakthroughs were recently featured on CBS 60 Minutes with Anderson Cooper EINDHOVEN, the Netherlands, May 21, 2025 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD and US OTCQX: ONWRY), the leading neurotechnology company pioneering t...
Ageas reports on the progress of share buy-back programme Ageas reports on the progress of share buy-back programme Further to the initiation of the share buy-back programme announced on 28 August 2024, Ageas reports the purchase of 70,414 Ageas shares in the period from 12-05-2025 until 16-05-2025. DateNumber ofSharesTotal amount(EUR)Average price(EUR)Lowest price(EUR)Highest price(EUR)12-05-202517,908997,98455.7355.4056.6513-05-202515,090838,76255.5855.4055.7514-05-202514,114787,99455.8355.4056.1015-05-20258,889499,79956.2356.0056.4516-05-202514,413817,00656.6956.5056.85Total70,4143,941...
Ageas reports on the progress of share buy-back programme Rapport d’Ageas sur le programme de rachat d’actions Dans le cadre du programme de rachat d’actions annoncé le 28 août 2024, Ageas indique que 70.414 actions Ageas ont été achetées durant la période du 12-05-2025 au 16-05-2025. DateNombred’actionsMontant total(EUR)Cours moyen(EUR)Cours le plus bas (EUR)Cours le plus élevé (EUR)12-05-202517.908997.98455,7355,4056,6513-05-202515.090838.76255,5855,4055,7514-05-202514.114787.99455,8355,4056,1015-05-20258.889499.79956,2356,0056,4516-05-202514.413817.00656,6956,5056,85Total70.4143.941.544...
Ageas rapporteert over de inkoop van eigen aandelen Ageas rapporteert over de inkoop van eigen aandelen Naar aanleiding van het aandelen-inkoopprogramma dat op 28 augustus 2024 aangekondigd werd, maakt Ageas bekend dat er 70.414 eigen aandelen ingekocht werden tussen 12-05-2025 en 16-05-2025. DatumAantalaandelenTotaal Bedrag(EUR)Gemiddelde koers(EUR)Laagste koers(EUR)Hoogste koers(EUR)12-05-202517.908997.98455,7355,4056,6513-05-202515.090838.76255,5855,4055,7514-05-202514.114787.99455,8355,4056,1015-05-20258.889499.79956,2356,0056,4516-05-202514.413817.00656,6956,5056,85Totaal70.4143.941.5...
Alfen: Dead cat bounce? Ayvens: Overhang cure. Belgian telcos: Hey! discontinues €5 offer, OBEL price increases from June 2025. B&S Group: Pulls FY EBITDA guidance in light of tariffs. D'Ieteren: CMD, 1Q25 Preview. Kendrion: Wrestling through difficult macro conditions. NN Group, ASR: Vote on Dutch pension reforms postponed. TKH Group: Not that bad, good progress at Eemshaven. UCB: US Most Favoured Nation initiative back on the agenda. Vastned: Good results, integration ongoing...
Ekopak announces a €15m capital increase led by Alychlo, alongside major board and management changes. The transaction strengthens governance and liquidity, with Alychlo becoming the dominant shareholder. New projects and reaffirmed credit lines support continued growth under the WaaS model. The transaction, management, and board changes clearly exemplify the intention of reference shareholder Alychlo to re-start with a clean slate and mark a first step in rebuilding investor confidence . We mai...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.